Fiber prevents the constipation that affects many GLP-1 users when slower digestion combines with reduced food intake
13 After 72 weeks, patients using tirzepatide 5 mg, 10 mg, and 15 mg experienced a weight loss of 15%, 19.5%, and 20.9%, respectively, compared with 3.1% in patients using placebo
Clinical evidence is evolving, and more research is required to fully establish long-term safety and efficacy
Microdosing semaglutide Some prescribers use doses below the standard starting point (less than 0.25 mg) for patients who are particularly sensitive to GLP-1 medications or who have a history of severe nausea with other medications
This is not about moving away from overall survival
What are the best non-laxative ways to relieve constipation on GLP-1 medications